13 Physicians who are associated with PRESERVE
Al Baha Barqawi, MD
Al Baha Barqawi, MD specializes in Urologic Oncology at UCHealth-Anschutz Medical Campus. He has more than 20 years of clinical expertise in the management of urologic cancer and general urology, primarily in prostate disease clinical research, early detection, novel minimally invasive treatment applications, and prevention. He pioneered the 3D imaging of the prostate gland, and targeted focal therapy for prostate cancer. Dr. Barqawi received his medical degree from Medical University of Varna, Bulgaria and completed his fellowship at FRCS (Glasgow) Fellow of The Royal College of Physicians and Surgeons of Glasgow, United Kingdom. He believes in better staging and imaging for prostate cancer as a prerequisite for the decision making process. Dr. Barqawi’s objective is to preserve the quality of life in his patients with cancer by developing individualized therapy.
David Chen, MD
Andres Correa, MD
Andres Correa, MD is an assistant professor in the division of Urology and Urologic Oncology at Fox Chase Cancer Center. He received his medical degree from University of Maryland School of Medicine and completed an internship in general surgery at the University of Pittsburgh Medical Center, where he became a urology resident and eventually chief resident of Urology.
Dr. Correa specializes in the management of the prostate, kidney, bladder, adrenal gland, testis, and penile cancer. He is skilled at surgical modalities including robotics, laparoscopy, and traditional open surgery, and has expertise in prostate, kidney, bladder, testicular, and other genitourinary cancers. Dr. Correa believes the best surgical approach is the one that maximizes patient safety and prompt post-operative recovery.
Thomas Frye, DO
Thomas Frye, D.O., is a Urologic Oncologist who specializes in minimally invasive urologic oncology (robotic surgery of bladder, prostate, and kidney cancers), advanced open pelvic and retroperitoneal cancer surgery, and detection and management of localized prostate cancer with magnetic resonance imaging (MRI).
Dr. Frye received his Osteopathy degree from Midwestern University where he was awarded valedictorian of his class. He did his residency training at Southern Illinois University School of Medicine and completed his fellowship in Urologic Oncology at National Cancer Institute/National Institute of Health.
Dr. Frye has clinical and research interests in prostate cancer and currently practices in Rochester, NY.
Jeffrey Gahan, MD
Jeffrey Gahan, MD is an associate professor of urology at UT Southwestern Medical Center and leads the highest volume urologic robotic surgery team in VA system. He received his medical degree from Baylor College of Medicine and completed his urology and surgery residencies at the University of Miami/ Jackson Memorial Hospital in Miami, Florida. He then completed his fellowship in Endourology and Minimally Invasive Surgery at the University of Texas Southwestern Medical Center.
Dr. Gahan’s primary research interests include the minimally invasive treatment of prostate cancer, renal carcinoma and benign prostate enlargement. He is particularly interested in the applications of engineering technology to urology and works closely with engineers from SMU and the UT system. He published over 65 peer reviewed articles and has given presentations on his work at numerous national and international conferences.
Clinically, he has been one of the pioneers developing a novel approach to prostate surgery dubbed the “Retzius Sparing Prostatectomy” which improves functional outcomes after prostate surgery. He also leads the implementation of a novel ablation technology, irreversible electroporation (nano knife), for the focal treatment of prostate cancer. In addition, he treats benign prostate enlargement using a number of technologies including holmium or thulium enucleation, aquablation and urolift. Lasty, he specializes in the complex reconstruction of upper tract ureteral strictures using buccal mucosal graft (tissue from the inner cheek) and ileal interposition (segment small intestine).
Arvin George, MD
Arvin George, MD is a Urologic Surgeon specializing in the diagnosis and management of genitourinary cancers. After obtaining his medical degree from the Royal College of Surgeons in Ireland, he completed his Urology Residency at the Smith Institute for Urology, Hofstra North Shore-LIJ School of Medicine. He remained to complete his Endourology fellowship in New York gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery. Subsequently, he completed a Urologic Oncology fellowship at the National Cancer Institute, National Institutes of Health. Dr. George’s clinical practice includes both surgical and non-operative management of prostate, kidney, ureteral, testicular, and bladder cancers. Dr. George’s research interests include minimally invasive and image-guided treatments, functional prostate imaging and focal therapy for prostate cancer.
Derek Lomas, M.D
Derek Lomas, MD is a Urologist at Mayo Clinic, Rochester, MN. He received his medical degree from Chicago Medical School at Rosalind Franklin University and completed his urology residency at Mayo Clinic. Following residency he completed additional fellowship training as a Mayo Clinic Scholar in the fields of Imaging, Targeted Biopsy, and Focal Therapy of Prostate Cancer.
Dr. Lomas’ clinical interests include prostate cancer diagnostics, trans-perineal prostate biopsy, prostate imaging, and focal therapy for prostate cancer including cryotherapy, high intensity focused ultrasound, and irreversible electroporation.
Ranko Miocinovic, MD
Ranko Miocinovic, MD is a Urologist with Duly Health and Care. He has 20 years of experience and is board certified in Urology and Robotic Surgery. Dr. Miocinovic received his medical degree from University of Toledo Medical Center and completed his fellowship at Cleveland Clinic, Urologic Oncology and Advanced Laparoscopic and Robotic Oncology. Dr. Miocinovic believes in “An approach to health and well being that includes not only most advanced treatments, but also considers patient beliefs and quality of life.”
Amit R. Patel, MD
Thomas Polascik, MD
Thomas Polascik, MD is a Professor of Surgery at Duke University Medical Center and the Director of Surgical Technology at the Duke Prostate and Urological Cancer Center. He received his medical degree from University of Chicago.
Dr. Polascik did his residency training in general surgery at Johns Hopkins Hospital in Baltimore, Maryland, and in urology at the James Buchanan Brady Urological Institute at Hopkins. He also completed a fellowship in urologic oncology at Johns Hopkins Hospital. Dr. Polascik’s clinical and research interests focus on prostate and kidney cancer. He has authored over 350 peer-reviewed manuscripts and book chapters. He currently serves as the President of the Focal Therapy Society.
Art Rastinehad, MD
Art Rastinehad, MD is the System Director of Prostate Cancer and Vice Chairman of Lenox Hill Urology at Northwell Health. He received his medical degree from NYIT College of Osteopathic Medicine.
Dr. Rastinehad trained at the National Cancer Institute as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship-trained in Urologic Oncology and Interventional Radiology. He has expertise in an array of interventional radiological and surgical techniques, including image guided procedures, laparoscopic and robotic surgery. Dr. Rastinehad continues to dedicate his time to caring for patients by researching and developing new diagnostic and therapeutic interventions for urologic diseases, as well as training the next generation of urologists.
Abhinav Sidana, MD
Abhinav Sidana, MD is an Associate Professor and Director of Urologic Oncology in the Division of Urology at University of Cincinnati Medical Center. His clinical practice includes both surgical and non-operative management of prostate and kidney cancers. Dr. Sidana received his medical degree from All India Institute of Medical Sciences, did his residency training at University of Cincinnati College of Medicine, and completed his fellowship at National Cancer Institute, National Institutes of Health.
Dr. Sidana is actively involved in urologic cancer research and his interests include functional prostate imaging, image-guided and focal treatments for prostate cancer and clinical trials on novel treatments for urologic cancers.
Srinivas Vourganti, MD
Dr. Vourganti is a robotic and minimally invasive urologic surgeon who specializes in the treatment of cancers of the prostate, bladder, kidney and ureter. He serves as an assistant professor in the Department of Urology at Rush University Medical Center.
Dr. Vourganti received his medical degree from Ohio State University College of Medicine and completed his residency at University Hospitals of Cleveland. While completing his fellowship at the National Cancer Institute, Dr. Vourganti collaborated with world experts in clinical care, basic science and engineering to develop new ideas and bring them to the clinic.
Dr. Vourganti’s research areas of interest include urologic cancer, prostate MRI, prostate cancer diagnosis and targeted therapy.